T1	Participants 113 189	patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex
T2	Participants 291 433	patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) who were intolerant to zidovudine because of neutropenia
T3	Participants 776 811	A total of 17 patients were entered
